Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

860 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study].
Chaparro M, Kunovský L, Aguas M, Livne M, Rivière P, Bar-Gil Shitrit A, Myrelid P, Arroyo M, Barreiro-de Acosta M, Bautista M, Biancone L, Biron IA, Boysen T, Carpio D, Castro B, Dragoni G, Ellul P, Holubar SD, de Jorge MÁ, Leo E, Manceñido N, Moens A, Molnár T, Ramírez de la Piscina P, Ricanek P, Sebkova L, Sempere L, Teich N, Gisbert JP, Julsgaard M. Chaparro M, et al. Among authors: molnar t. J Crohns Colitis. 2022 Sep 8;16(9):1428-1435. doi: 10.1093/ecco-jcc/jjac050. J Crohns Colitis. 2022. PMID: 35380641 Free article.
Bolus administration of steroid therapy is more favorable than the conventional use in preventing decrease of bone density and the increase of body fat percentage in patients with inflammatory bowel disease.
Farkas K, Bálint A, Valkusz Z, Szepes Z, Nagy F, Szűcs M, Bor R, Wittmann T, Molnár T. Farkas K, et al. Among authors: molnar t. J Crohns Colitis. 2014 Sep;8(9):992-7. doi: 10.1016/j.crohns.2014.01.026. Epub 2014 Feb 14. J Crohns Colitis. 2014. PMID: 24530134 Clinical Trial.
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.
Gecse KB, Lovász BD, Farkas K, Banai J, Bene L, Gasztonyi B, Golovics PA, Kristóf T, Lakatos L, Csontos ÁA, Juhász M, Nagy F, Palatka K, Papp M, Patai Á, Lakner L, Salamon Á, Szamosi T, Szepes Z, Tóth GT, Vincze Á, Szalay B, Molnár T, Lakatos PL. Gecse KB, et al. Among authors: molnar t. J Crohns Colitis. 2016 Feb;10(2):133-40. doi: 10.1093/ecco-jcc/jjv220. Epub 2015 Dec 10. J Crohns Colitis. 2016. PMID: 26661272 Clinical Trial.
Tofacitinib Therapy, the Lender of Last Resort.
Rutka M, Pigniczki D, Molnár T. Rutka M, et al. Among authors: molnar t. J Crohns Colitis. 2021 Apr 6;15(4):694. doi: 10.1093/ecco-jcc/jjaa198. J Crohns Colitis. 2021. PMID: 32978625 No abstract available.
Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies.
Pauwels RWM, van der Woude CJ, Nieboer D, Steyerberg EW, Casanova MJ, Gisbert JP, Kennedy NA, Lees CW, Louis E, Molnár T, Szántó K, Leo E, Bots S, Downey R, Lukas M, Lin WC, Amiot A, Lu C, Roblin X, Farkas K, Seidelin JB, Duijvestein M, D'Haens GR, de Vries AC; CEASE Study Group. Pauwels RWM, et al. Among authors: molnar t. Clin Gastroenterol Hepatol. 2022 Aug;20(8):1671-1686.e16. doi: 10.1016/j.cgh.2021.03.037. Epub 2021 Apr 30. Clin Gastroenterol Hepatol. 2022. PMID: 33933376 Free article. Review.
860 results